×

Three-year follow-up of Phase 1 and 2a rAAV.sFLT-1 subretinal gene therapy trials for exudative age related macular degeneration.

Three-year follow-up of Phase 1 and 2a rAAV.sFLT-1 subretinal gene therapy trials for exudative age related macular degeneration.

Rakoczy EP, Magno AL, Lai CM, Pierce CM, Degli-Esposti MA, Blumenkranz MS, Constable IJ.

Am J Ophthalmol. 2019 Mar 13. pii: S0002-9394(19)30104-7. doi: 10.1016/j.ajo.2019.03.006. [Epub ahead of print]

PMID: 30878487 IF 4.483

Need any help?

If you would like to know more about us, or want to make an appointment, please don’t hesitate to get in touch.

Request an appointment